Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Other Non-Current Assets (2023 - 2025)

Historic Other Non-Current Assets for Bioadaptives (BDPT) over the last 3 years, with Q3 2025 value amounting to $2500.0.

  • Bioadaptives' Other Non-Current Assets changed 0.0% to $2500.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2500.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $2500.0 for FY2024, which is 0.0% changed from last year.
  • Per Bioadaptives' latest filing, its Other Non-Current Assets stood at $2500.0 for Q3 2025, which was down 0.0% from $2500.0 recorded in Q2 2025.
  • Over the past 5 years, Bioadaptives' Other Non-Current Assets peaked at $2500.0 during Q4 2023, and registered a low of $2500.0 during Q4 2023.
  • Moreover, its 3-year median value for Other Non-Current Assets was $2500.0 (2023), whereas its average is $2500.0.
  • Within the past 5 years, the most significant YoY rise in Bioadaptives' Other Non-Current Assets was 0.0% (2024), while the steepest drop was 0.0% (2024).
  • Bioadaptives' Other Non-Current Assets (Quarter) stood at $2500.0 in 2023, then changed by 0.0% to $2500.0 in 2024, then changed by 0.0% to $2500.0 in 2025.
  • Its last three reported values are $2500.0 in Q3 2025, $2500.0 for Q2 2025, and $2500.0 during Q1 2025.